期刊文献+

强脉冲光治疗面部皮脂溢出症的临床疗效观察 被引量:3

原文传递
导出
摘要 皮脂溢出症是一种常见的疾病,也是其他脂溢性皮肤病,如脂溢性皮炎、痤疮、脂溢性脱发及酒渣鼻等发病的共同基础。主要发生在颜面、头皮、胸等部位,影响美观。其发病受多种因素的影响,如环境、饮食、年龄等。日前尚缺乏有效的治疗方法。
出处 《中华医学美学美容杂志》 2012年第4期303-304,共2页 Chinese Journal of Medical Aesthetics and Cosmetology
  • 相关文献

参考文献6

  • 1Fitzpathick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol, 1988, 124 ( 6 ) : 869- 871.
  • 2Anderson RR, Parrish JA. The optics of human skin. J Invest Dermatol, 1981,77(1):13.
  • 3Weiss RA, Goldman MP, Weiss MA. Treatment of poikiloder- ma of Civatte with an intense pulsed light source, Dermalol Surg, 2000,26(9) :823-828.
  • 4李宜辉 ,赵晓晏 ,杨恬 ,张艺 ,向明明 .毛囊干细胞和皮脂腺的发育与维持[J].重庆医学,2004,33(10):1572-1576. 被引量:4
  • 5Bitter PH. Noninvasive rejuvenation of photodamaged skin us- ingserial, full-face intense pulsed light treatments. Dermatol Surg, 2000,26(9) :835-843.
  • 6Ptieto VG, Sadick NS, Lloreta J, et al. Effecls of intense pulsed light on sun-damaged huaman skin. routine, and ultra- structural analysis. Lsers Surg Med, 2002,30(2):82-85.

二级参考文献22

  • 1Doran TI,Baff R,Jacoba P,et al.Characterization of human sebaceous cells in vitro[J].J Invest Dermatol,1991,96:341
  • 2Miller SJ,Lavker RM,TT Sun.Keratinocyte stem cells of cornea,skin and hair follicles[M].New York:Academic Press,USA,1997.1
  • 3Lavker RM,Miller S,Wilson C,et al.Hair follicle stem cells:their location,role in hair cycle,and involvement in skin tumor formation[J].J Invest Dermatol,1993,101(1 suppl):16s
  • 4Oshima H,Rochat A,Kedzia C,et al.Morphogenesis and renewal of hair follicle from adult multipotene stem cells[J].Cell,2001,104:233
  • 5Panteleyev AA,Rosenbach T,Paus R,et al.The bulge is the source of cellular renewal in the sebaceous gland of mouse skin[J].Arch Dermatol Res,2000,292:573
  • 6Zouboulis CC,Xia L,Akamatsu H,et al.The human sebocyte culture model provides new insights into development and management of seborrhoea and acne[J].Dermatology,1998,196:21
  • 7Gat U,DasGupta R,Degenstein L,et al.De Novo hair follicle morphogenesis and hair tumors in mice expressing a truncated beta-catenin in skin[J].Cell,1998,95:605
  • 8Niemann C,Watt FM.Designer skin:lineage commitment in postnatal epidermis[J].Trends Cell Biol,2002,12:185
  • 9Arnold I,Watt FM.c-Myc activation in transgenic mouse epidermis results in mobilization of stem cells and differentiation of their progeny[J].Curr Biol,2001,11:558
  • 10Jensen PJ,T Yang.Serpins in the human hair follicle[J].JID,2000,114:917

共引文献3

同被引文献31

  • 1JamesWD,BergerTG,EletonDM.安德鲁斯临床皮肤病学[M].北京:科学出版社,2012:188.
  • 2Draelos ZD, Feldman SR, Butners V, et al. Long-term safety of ketoconazole foam,2%in the treatment of seborrheic dermatitis: results of a phase IV, open-label study [J]. J drugs Dermatol, 2013, 12(1):e1-6.
  • 3Goldust M, Rezaee E, Rouhani S. Double blind study of sertaconazole 2% cream vs. clotrimazole 1% cream in treatment of seborrheic dermatitis [J]. Ann Parasitol, 2013, 59(1):25-29.
  • 4Goldust M, Rezaee E, Ragbifor R, etal. Treatment of seborrheic dermatitis:comparison of sertaconazole 2% cream versus pimecrolimus 1% cream [J]. Ir J Med Sci, 2013, 182(4):703-706.
  • 5Goldust M, Rezaee E, Masoadnia S, et al. Clinical study of sertaconazole 2% cream vs. hydrocortisone 1% cream in the treatment of seborrheic dermatitis [J]. Ann Parasitol, 2013, 59(3): 119-123.
  • 6Goldust M, Rezaee E, Reghifar R, et al. A double blind study of the effectiveness of sertaconazole 2% cream vs. metronidazole 1% gel in the treatment of seborrheic dermatitis [J]. Annnals of Darasitol, 2013, 59(4):173-177.
  • 7Elewski BE, Cantrell WC. An open-label study of the safety and efficacy of sertaconazole nitrate in the treatment of seborrheic dermatitis [J]. J Drugs Dermatol, 2011, 10(8):895-909.
  • 8Papp KA, Papp A, Dahmer B, et al. Singal-blind, randomized controlled trial evaluating the treatment of facial seborrheic dermatitis with hydrocortisone 1% ointment compared with tacrolimus 0.1% ointment in adults [J]. J Am Acad Dermatol, 2012, 67( 1):e11-15.
  • 9Ozden MG, Tekin NS, IIter N, et al. Topical pimecrolimus 1% cream for resistant seborrheic dermatitis of the face:an open-label study [J]. Am J Clin Dermatol, 2010, 11(1):51-54.
  • 10Tatlican S, Eren C, Oktay B, et al. Experience with repetitive use of pimecrolimus:exploring the effective and safe use in the treatment of replasing seborrheic dermatitis [J]. J Dermatology Treat, 2009, 21(2):83-85.

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部